Pantothenic Acid
Evidence status
Limited evidence to recommend for any consumer outcome yet.
2 papers · 0 claims · 8 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
Diarrhea moderate
Flatulence mild
fatigue
shingles
treatment-emergent adverse events (overall)
Gastrointestinal disorders
Infections and infestations
General disorders and administration site conditions
Drug interactions
Pyrazinamide major decreases effect
Cisplatin moderate decreases effect
Tacrolimus moderate decreases concentration
Isoniazid minor unknown
Sources
- 1. A randomized, double-blind, placebo-controlled study of a novel pantothenic Acid-based dietary supplement in subjects with mild to moderate facial acne. (2014) ↑
- 2. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation. (2014) ↑
Generated August 14, 2026